Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EBMT 2020 | RACE: evaluating eltrombopag in severe aplastic anemia

Régis Peffault de Latour, MD, PhD, Saint-Louis Hospital, Paris, France, presents results from the RACE trial (NCT02099747), a prospective, randomized multicenter study comparing horse antithymocyte globulin and cyclosporine A with or without eltrombopag as front-line therapy for severe aplastic anemia patients. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).